10x Genomics Inc (LTS:0A88)
$ 15.84 0.33 (2.13%) Market Cap: 1.92 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 2.66 GF Score: 64/100

Q4 2023 10X Genomics Inc Earnings Call Transcript

Feb 15, 2024 / 09:30PM GMT
Release Date Price: $48.75 (+1.67%)
Operator

Good afternoon. My name is Jeannie, and I will be your conference operator today. I would like to welcome you to the 10x Genomics Fourth Quarter and Full Year 2023 Earnings Conference Call. (Operator Instructions).

I would now like to turn the conference over to Cassie Corneau. You may begin your conference.

Cassie Corneau
10x Genomics, Inc. - Manager of IR and Strategic Finance

Thank you, and good afternoon, everyone. Earlier today, 10x Genomics released financial results for the fourth quarter and full year ended December 31, 2023. If you have not received this news release or if you would like to be added to the company's distribution list, please send an e-mail to [email protected]. An archived webcast of this call will be available on the Investor tab of the company's website, 10xgenomics.com, for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot